Available in your pharmacy for CHF 24.90!
About 45-100% of patients suffer from toxic-epidermal side effects. The most common reactions include papulopustular rash, dry and itchy skin, inflammation around the nails, loss of hair but increased growth of eyelashes and facial hair.
Acne-like rash is present in 80% of all patients and mainly affects the face, torso and head. A successful therapeutic outcome of the cancer treatment often correlates with the application of Reconval K1.
Side effects while cancer treatment and radiotherapy can cause painful, diffuse and symmetric erythema or oedema of the hands and feet.
The skin on the palms and soles painfully peels off. Reconval B6 prevents this undesired effect and alleviates existing inflammations.